Stocks

Spouse of Intel Committee Member Makes Timely Quantum Stock Purchase

By David Moore,

Published on Apr 16, 2026   —   5 min read

Greg Steubequantum computingIonQMAGA
Rep. Greg Steube (R-FL) arrives for a House Republican Conference meeting at the U.S. Capitol on March 11, 2025. (Kayla Bartkowski/Getty Images)

Summary

MAGA Rep. Greg Steube’s spouse bought stock last month in a quantum computing company whose share price boomed when it reached a technical milestone and was awarded a defense contract.

📈
Share this on Bluesky and X

The spouse of a House Intelligence Committee member bought stock in the quantum computing firm IonQ just weeks before the company announced it was awarded a contract with the Defense Advanced Research Projects Agency (DARPA). IonQ’s stock has spiked by a third since the announcement on Tuesday.

Rep. Greg Steube (R-Fla.) became a member of the House Permanent Select Committee on Intelligence last year, a panel that largely meets in closed sessions and routinely receives classified reports from the Director of National Intelligence and other intelligence community figures. Under the committee’s rules, all members shall have access to all classified papers and other material received by the Committee from any source. This broad access includes sensitive intelligence on national security topics including emergent technology like quantum computing and artificial intelligence.

A financial disclosure filed with the House Clerk shows his spouse, Jennifer M. Steube, purchased up to $15,000 worth of IonQ stock on March 18. She works as a senior trust portfolio manager with financial services firm Synovus.

Prior to the pickup, her last stock buy had been in July 2025, when she purchased shares of General Motors. The shares in IonQ are the only technology stock in her portfolio. No member of Congress or their household has previously bought or sold IonQ’s stock, according to Capitol Trades, which maintains a public archive of congressional stock trades since 2023. 

Read This Post With a Free Trial

Unlock this post plus get our investigative reports with a two-week free trial subscription. Cancel anytime.

Start your free trial now

Already have an account? Sign in

Share on Facebook Share on Linkedin Share on Twitter Send by email

Unlock exclusive content with a free trial

Get unlimited access to in-depth investigative reports with a 14-day free trial. Cancel anytime.

Subscribe